Developer docs
API playgroundTry for free, no card

Search company profiles

Decision Lab

Full company profile

uuid000hj5c

Namestring
Decision Lab
Legal namestring
Decision Lab Ltd
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Decision Lab Ltd is a London-based, privately held company founded in 2011 that operates in the digital twin technology space with a stated focus on healthcare applications. According to available source material, the company is positioned as a key player in the U.S. digital twins in healthcare market — a sector valued at US$942.87 million in 2024 and projected to reach US$7,184.78 million by 2033 at a 25.7% CAGR. The company's stated functional scope covers treatment planning, drug discovery, diagnostics, patient monitoring, and healthcare facility management, all of which rely on simulation and predictive analytics enabled by digital twin architectures.

The company operates with a small team of 11–50 employees and serves healthcare providers and life sciences organizations as its primary customer vertical. Its operating geographies include North America (United States and Canada) and Latin America, indicating a cross-Atlantic commercial posture despite the UK headquarters (decisionlab.co.uk). The company describes itself as providing services that solve real-world challenges for some of the biggest and most respected businesses, though specific named customers, product names, pricing models, revenue figures, and management team details are not disclosed in the available sources. No funding rounds, mergers, acquisitions, partnerships, awards, patents, or leadership changes are documented in the input data.

The business model is not explicitly disclosed; no pricing structure, revenue mechanics, or go-to-motion details are available. Decision Lab is listed alongside established players such as GE Healthcare and Twin Health in the same market context, but no competitive differentiation evidence (proprietary technology, customer wins, or technical benchmarks) is provided. Evidence gaps — particularly around revenue, customers, leadership, and product portfolio — limit confident assessment of scale, unit economics, and growth cadence.

Short descriptiontext

Decision Lab is a London-based private company that develops digital twin technology for healthcare applications, serving healthcare providers and life sciences organizations across North America and Latin America.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLoughborough, United Kingdom
HQ citystring
Loughborough
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
digital twin technology, healthcare simulation, treatment planning software, medical predictive analytics, drug discovery analytics
Industry3 codes
PRIMARYHLACAGAA
Diagnostic & Triage Decision Support
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools
SECONDARYHLACAMAK
Lab Analytics, Utilization Management & Operational Intelligence
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code3 codes
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Scientific Research and Development Services5417
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Healthcare Digital Twin Software
Social media profiles2 records
Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Decision Lab provides digital twin technology applied to healthcare, enabling simulation and predictive analytics for treatment planning, drug discovery, diagnostics, patient monitoring, and healthcare facility management. The offering is targeted at healthcare providers and life sciences organizations seeking personalized medicine and treatment optimization capabilities.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Decision Lab Ltd is identified as a key player in the U.S. digital twins in healthcare market. The available source data does not provide specific information about the company's individual products, modules, or service offerings. Based on the market context, the company appears to be involved in healthcare simulation and digital twin technology, but no named products or detailed portfolio information is available in the provided sources.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Siemens Healthineers operates a broad portfolio in medical imaging, diagnostics, and digital health, including digital twin simulations for cardiovascular and oncology applications. Comparable as a large incumbent offering digital twin solutions within a wider healthcare portfolio.

TypeDirect peer
Description

Twin Health builds AI-driven digital twin platforms for personalized whole-body metabolic care, primarily in chronic disease management. Directly comparable as a digital twin healthcare specialist explicitly cited alongside Decision Lab as a key market player.

TypeBroad incumbent
Description

GE Healthcare is a major medical technology and digital solutions provider with growing digital twin capabilities across imaging, asset management, and care delivery. Cited in the source data as an established player alongside Decision Lab in the digital twins in healthcare market.

TypeBroad incumbent
Description

Philips HealthSuite integrates connected health devices, clinical informatics, and patient monitoring, increasingly incorporating digital twin concepts for care pathways. A broad incumbent with overlapping patient monitoring and clinical decision support offerings.

TypeEmerging player
Description

Q Bio builds a whole-body digital twin platform combining imaging and clinical data for preventive health assessments. Comparable as an emerging digital twin healthcare company focused on diagnostics and patient monitoring.

TypeEmerging player
Description

HeartFlow creates patient-specific 3D digital heart models from CT imaging to support diagnosis and treatment planning for coronary artery disease. Comparable as a clinical decision support company whose core product is a patient-level digital twin.

7Unlearn.AI
TypeEmerging player
Description

Unlearn.AI builds AI-generated digital twin prognostic models to improve clinical trial efficiency and biopharma R&D. Comparable as an emerging specialist applying digital twin methodology to drug discovery and clinical research workflows.

TypeDirect peer
Description

Dassault Systèmes' Living Heart Project applies digital twin simulation to cardiac and broader life sciences R&D and treatment planning. Directly comparable in using digital twins for treatment planning, drug discovery, and diagnostics in healthcare.

TypeEmerging player
Description

Virtonomy provides patient-specific digital twin simulations for medical device design, clinical trials, and in-silico testing. Comparable as an emerging digital twin specialist serving life sciences R&D and treatment planning use cases.

TypeEmerging player
Description

Materialise provides 3D planning, patient-specific anatomical models, and digital twin tools for surgical planning and personalized care. Comparable as a specialist applying digital modeling to diagnostics, treatment planning, and healthcare simulation.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Decision Lab

Healthcare Digital Twin Softwaredecisionlab.co.uk

Decision Lab is a London-based private company that develops digital twin technology for healthcare applications, serving healthcare providers and life sciences organizations across North America and Latin America.

What Decision Lab does

Decision Lab Ltd is a London-based, privately held company founded in 2011 that operates in the digital twin technology space with a stated focus on healthcare applications. According to available source material, the company is positioned as a key player in the U.S. digital twins in healthcare market — a sector valued at US$942.87 million in 2024 and projected to reach US$7,184.78 million by 2033 at a 25.7% CAGR. The company's stated functional scope covers treatment planning, drug discovery, diagnostics, patient monitoring, and healthcare facility management, all of which rely on simulation and predictive analytics enabled by digital twin architectures.

The company operates with a small team of 11–50 employees and serves healthcare providers and life sciences organizations as its primary customer vertical. Its operating geographies include North America (United States and Canada) and Latin America, indicating a cross-Atlantic commercial posture despite the UK headquarters (decisionlab.co.uk). The company describes itself as providing services that solve real-world challenges for some of the biggest and most respected businesses, though specific named customers, product names, pricing models, revenue figures, and management team details are not disclosed in the available sources. No funding rounds, mergers, acquisitions, partnerships, awards, patents, or leadership changes are documented in the input data.

The business model is not explicitly disclosed; no pricing structure, revenue mechanics, or go-to-motion details are available. Decision Lab is listed alongside established players such as GE Healthcare and Twin Health in the same market context, but no competitive differentiation evidence (proprietary technology, customer wins, or technical benchmarks) is provided. Evidence gaps — particularly around revenue, customers, leadership, and product portfolio — limit confident assessment of scale, unit economics, and growth cadence.

Decision Lab firmographics

Firmographics
Name
Decision Lab
Legal name
Decision Lab Ltd
Website
https://decisionlab.co.uk
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
Decision Lab is a London-based private company that develops digital twin technology for healthcare applications, serving healthcare providers and life sciences organizations across North America and Latin America.
Ownership category
akta.pro rank

Decision Lab industry classification

Industry
Product category
Healthcare Digital Twin Software
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLACAGAA
Diagnostic & Triage Decision Support
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools
SECONDARYHLACAMAK
Lab Analytics, Utilization Management & Operational Intelligence
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Digital twin technology
  • Healthcare simulation
  • Treatment planning software
  • Medical predictive analytics
  • Drug discovery analytics

Where Decision Lab is headquartered

Location

Headquarters

HQ city
Loughborough
HQ country
United Kingdom
HQ region
Europe

Markets served

Decision Lab business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Decision Lab product offering

Product offering

Core offering

Decision Lab provides digital twin technology applied to healthcare, enabling simulation and predictive analytics for treatment planning, drug discovery, diagnostics, patient monitoring, and healthcare facility management. The offering is targeted at healthcare providers and life sciences organizations seeking personalized medicine and treatment optimization capabilities.

Product overview

Decision Lab Ltd is identified as a key player in the U.S. digital twins in healthcare market. The available source data does not provide specific information about the company's individual products, modules, or service offerings. Based on the market context, the company appears to be involved in healthcare simulation and digital twin technology, but no named products or detailed portfolio information is available in the provided sources.

Differentiator

Problem solved

Functional benefit

Companies that use Decision Lab

Customer profile

Segments1 record

Ideal customer profiles1 record

Decision Lab technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Decision Lab partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves3 records

Expansion highlights2 records

Decision Lab competitors and assessment

Company assessment

Broad incumbents

  • Siemens Healthineers: Siemens Healthineers operates a broad portfolio in medical imaging, diagnostics, and digital health, including digital twin simulations for cardiovascular and oncology applications. Comparable as a large incumbent offering digital twin solutions within a wider healthcare portfolio.
  • GE Healthcare: GE Healthcare is a major medical technology and digital solutions provider with growing digital twin capabilities across imaging, asset management, and care delivery. Cited in the source data as an established player alongside Decision Lab in the digital twins in healthcare market.
  • Philips HealthSuite: Philips HealthSuite integrates connected health devices, clinical informatics, and patient monitoring, increasingly incorporating digital twin concepts for care pathways. A broad incumbent with overlapping patient monitoring and clinical decision support offerings.

Direct peers

  • Twin Health: Twin Health builds AI-driven digital twin platforms for personalized whole-body metabolic care, primarily in chronic disease management. Directly comparable as a digital twin healthcare specialist explicitly cited alongside Decision Lab as a key market player.
  • Dassault Systèmes (Living Heart Project): Dassault Systèmes' Living Heart Project applies digital twin simulation to cardiac and broader life sciences R&D and treatment planning. Directly comparable in using digital twins for treatment planning, drug discovery, and diagnostics in healthcare.

Emerging players

  • Q Bio: Q Bio builds a whole-body digital twin platform combining imaging and clinical data for preventive health assessments. Comparable as an emerging digital twin healthcare company focused on diagnostics and patient monitoring.
  • HeartFlow: HeartFlow creates patient-specific 3D digital heart models from CT imaging to support diagnosis and treatment planning for coronary artery disease. Comparable as a clinical decision support company whose core product is a patient-level digital twin.
  • Unlearn.AI: Unlearn.AI builds AI-generated digital twin prognostic models to improve clinical trial efficiency and biopharma R&D. Comparable as an emerging specialist applying digital twin methodology to drug discovery and clinical research workflows.
  • Virtonomy: Virtonomy provides patient-specific digital twin simulations for medical device design, clinical trials, and in-silico testing. Comparable as an emerging digital twin specialist serving life sciences R&D and treatment planning use cases.
  • Materialise (Medical): Materialise provides 3D planning, patient-specific anatomical models, and digital twin tools for surgical planning and personalized care. Comparable as a specialist applying digital modeling to diagnostics, treatment planning, and healthcare simulation.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

Decision Lab social profiles

Digital presence

Decision Lab financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Decision Lab leadership team

Management profile

Number of profiles

Decision Lab funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Decision Lab M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Decision Lab

What does Decision Lab do?

Decision Lab provides digital twin technology applied to healthcare, enabling simulation and predictive analytics for treatment planning, drug discovery, diagnostics, patient monitoring, and healthcare facility management. The offering is targeted at healthcare providers and life sciences organizations seeking personalized medicine and treatment optimization capabilities.

Is Decision Lab a public or private company?

Decision Lab is a private company. It is classified as unknown and is currently operating.

When was Decision Lab founded?

Decision Lab was founded in 2011. It employs 11 to 50 people.

Where is Decision Lab based?

Decision Lab is headquartered in Loughborough, United Kingdom, in the Europe region.

Who are Decision Lab's main competitors?

Broad incumbents on record are Siemens Healthineers, GE Healthcare and Philips HealthSuite. Direct peers are Twin Health and Dassault Systèmes (Living Heart Project). Emerging players are Q Bio, HeartFlow, Unlearn.AI, Virtonomy and Materialise (Medical).

Does Decision Lab have an API?

No public API is recorded for Decision Lab.

What industry is Decision Lab in?

Decision Lab's product category is Healthcare Digital Twin Software. Its primary akta.pro industry code is HLACAGAA, Diagnostic & Triage Decision Support, with a secondary code of HLACAMAK, Lab Analytics, Utilization Management & Operational Intelligence. Its NAICS code is 54171 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals